Takeda Pharmaceutical (NYSE: TAK)
Takeda Pharmaceutical Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Takeda Pharmaceutical Company Info
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
News & Analysis
One Ultra-Cheap High-Yield Dividend Stock to Buy
Now may be a good time for dividend investors to consider loading up on this stock.
Better High Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
One of these high-yield pharma stocks stands out as a better buy right now.
2 Ultra-Cheap High-Yield Dividend Stocks to Buy Now
These two high-yield dividend stocks are attractive buys right now.
2 Beaten-Down Dividend Stocks That Haven't Been This Cheap In More Than a Decade
Is now the time to load up on these high-yielding investments?
3 High-Yielding Dividend Stocks Near Their 52-Week Lows
These stocks all pay far higher than the S&P 500 average dividend yield of 1.8%.
Got $5,000? These 2 Dividend Stocks Haven't Been This Cheap in Years
These stocks both yield more than three times the S&P 500 average.
Want Loads of Passive Income? Avoid These 3 (Very) Tempting Mistakes
Improving your investing process tends to have high returns.
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond
These three healthcare stocks should hold their value for years.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.